MYCN and neuroblastoma: Furthermore, even in non-MYCN-amplified tumours, a MYCN-amplified transcriptional signature is observed (Valentijn et al., 2012), and levels of c-Myc can also be elevated (Mestdagh et al., 2010), together suggesting that Myc signalling is an underlying driver of NB tumorigenesis.